1
Clinical Trials associated with MSC-Derived Secretome(University of the Punjab) / Not yet recruitingEarly Phase 1IIT Investigating the Safety and Regenerative Potential of MSC-Derived Secretome Combined With PRGF in Knee Osteoarthritis
This Phase I/II randomized clinical trial investigates the safety, feasibility, and early regenerative potential of intra-articular administration of mesenchymal stem cell (MSC)-derived secretome combined with Plasma Rich in Growth Factors (PRGF) in patients with knee osteoarthritis (KOA). The study aims to assess whether this cell-free, biologically enriched therapeutic combination can reduce pain, improve joint function, and promote cartilage repair.
100 Clinical Results associated with MSC-Derived Secretome(University of the Punjab)
100 Translational Medicine associated with MSC-Derived Secretome(University of the Punjab)
100 Patents (Medical) associated with MSC-Derived Secretome(University of the Punjab)
100 Deals associated with MSC-Derived Secretome(University of the Punjab)